Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ewa Stobiecka"'
Autor:
Agnieszka Czarniecka, Marcin Zeman, Grzegorz Wozniak, Adam Maciejewski, Ewa Stobiecka, Ewa Chmielik, Malgorzata Oczko-Wojciechowska, Jolanta Krajewska, Daria Handkiewicz-Junak, Barbara Jarzab
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Optimal therapeutic strategy in low advanced papillary thyroid carcinoma (PTC) is still a matter of debate. The management differs depending on the country.A prospective non-randomized study was performed to evaluate whether less extensive surgery co
Externí odkaz:
https://doaj.org/article/ef566eb075d04377acdca7889f0fa79d
Autor:
Michał Jarząb, Ewa Stobiecka, Agnieszka Badora-Rybicka, Ewa Chmielik, Małgorzata Kowalska, Wiesław Bal, Anna Polakiewicz-Gilowska, Barbara Bobek-Billewicz, Dariusz Lange, Rafał Tarnawski
Publikováno v:
Polish Journal of Pathology, Vol 70, Iss 2, Pp 91-99 (2019)
Currently, breast cancer chemotherapy response can be predicted based on various parameters, with common reporting of tumour grade and Ki67 proliferation index. We analysed their association with pathological complete response (pCR) in a multivariate
Externí odkaz:
https://doaj.org/article/54e543275bb84b828e304162f0be70c2
Autor:
Agnieszka Czarniecka, Monika Kowal, Dagmara Rusinek, Jolanta Krajewska, Michal Jarzab, Ewa Stobiecka, Ewa Chmielik, Ewa Zembala-Nozynska, Stanislaw Poltorak, Aleksander Sacher, Adam Maciejewski, Jadwiga Zebracka-Gala, Dariusz Lange, Malgorzata Oczko-Wojciechowska, Daria Handkiewicz-Junak, Barbara Jarzab
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132821 (2015)
INTRODUCTION:The risk of over-treatment in low-advanced PTC stages has prompted clinicians to search for new reliable prognostic factors. The presence of BRAF mutation, the most frequent molecular event in PTC, seems to be a good candidate. However,
Externí odkaz:
https://doaj.org/article/5cd2108e868e432586b7785576b2a50a
Autor:
Barbara Jarząb, Marek Dedecjus, Andrzej Lewiński, Zbigniew Adamczewski, Elwira Bakuła-Zalewska, Agata Bałdys-Waligórska, Marcin Barczyński, Magdalena Biskup-Frużyńska, Barbara Bobek-Billewicz, Artur Bossowski, Monika Buziak-Bereza, Ewa Chmielik, Agnieszka Czarniecka, Rafał Czepczyński, Jarosław Ćwikła, Katarzyna Dobruch-Sobczak, Janusz Dzięcioł, Aneta Gawlik, Jacek Gawrychowski, Daria Handkiewicz-Junak, Jerzy Harasymczuk, Alicja Hubalewska-Dydejczyk, Joanna Januszkiewicz-Caulier, Michał Jarząb, Krzysztof Kaczka, Michał Kalemba, Grzegorz Kamiński, Małgorzata Karbownik-Lewińska, Andrzej Kawecki, Aneta Kluczewska-Gałka, Agnieszka Kolasińska-Ćwikła, Magdalena Kołton, Aleksander Konturek, Beata Kos-Kudła, Agnieszka Kotecka-Blicharz, Aldona Kowalska, Jolanta Krajewska, Andrzej Kram, Leszek Królicki, Aleksandra Kukulska, Michał Kusiński, Krzysztof Kuzdak, Dariusz Lange, Aleksandra Ledwon, Ewa Małecka‑Tendera, Przemysław Mańkowski, Bartosz Migda, Marek Niedziela, Małgorzata Oczko-Wojciechowska, Dariusz Polnik, Lech Pomorski, Marek Ruchała, Konrad Samborski, Anna Skowrońska-Szcześniak, Agata Stanek-Widera, Ewa Stobiecka, Zoran Stojčev, Magdalena Suchorzepka-Simek, Anhelli Syrenicz, Ewelina Szczepanek-Parulska, Małgorzata Trofimiuk‑Müldner, Andrzej Tysarowski, Andrzej Wygoda, Klaudia Zajkowska, Ewa Zembala-Nożyńska, Agnieszka Żyłka
Publikováno v:
Endokrynologia Polska. 73:173-300
The guidelines Thyroid Cancer 2022 are prepared based on previous Polish recommendations updated in 2018. They consider international guidelines - American Thyroid Association (ATA) 2015 and National Comprehensive Cancer Network (NCCN); however, they
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bab496c16f9285d405c8ebba8ba414ca
https://doi.org/10.5603/ep.a2022.0028
https://doi.org/10.5603/ep.a2022.0028
Autor:
Agnieszka Czarniecka, Grzegorz Wozniak, Marcin Zeman, Michal Kalemba, Zbigniew Wygoda, Ewa Chmielik, Ewa Stobiecka, Cortez Alexander J., Jolanta Krajewska, Daria Handkiewicz-Junak
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c7daf81dae40c2ba51438ba0d48b827
https://doi.org/10.1530/endoabs.84.op-03-13
https://doi.org/10.1530/endoabs.84.op-03-13
Autor:
Agnieszka Skorupa, Mateusz Ciszek, Maria Turska-d’Amico, Ewa Stobiecka, Ewa Chmielik, Ryszard Szumniak, Andrea d’Amico, Łukasz Boguszewicz, Maria Sokół
Publikováno v:
Cancers; Volume 15; Issue 4; Pages: 1283
Breast tumors constitute the complex entities composed of cancer cells and stromal components. The compositional heterogeneity should be taken into account in bulk tissue metabolomics studies. The aim of this work was to find the relation between the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e13a10240b4c7edb8f8a919ad7306a2d
https://doi.org/10.3390/cancers15041283
https://doi.org/10.3390/cancers15041283
Autor:
Jolanta Krajewska, Daria Handkiewicz-Junak, Ewa Chmielik, Grzegorz Wozniak, Adam Maciejewski, Malgorzata Oczko-Wojciechowska, Ewa Stobiecka, Agnieszka Czarniecka, Barbara Jarzab, Marcin Zeman
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, Vol 12 (2021)
Optimal therapeutic strategy in low advanced papillary thyroid carcinoma (PTC) is still a matter of debate. The management differs depending on the country.A prospective non-randomized study was performed to evaluate whether less extensive surgery co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6467a1edfe7bddfae7fbb82609bf5214
https://doi.org/10.3389/fendo.2021.718833
https://doi.org/10.3389/fendo.2021.718833
Autor:
Marcin Rajczykowski, Katarzyna Galwas-Kliber, Ewa Stobiecka, Iwona Dębosz-Suwińska, Adam Idasiak, Jolanta Mrochem-Kwarciak, Rafał Suwiński, Marcin Zeman
Publikováno v:
Neoplasma. 68(3)
We investigated the tumor regression grading (TRG) as a prognostic marker for disease-free survival (DFS) in patients with advanced rectal cancer treated within phase III randomized study (ClinicalTrials.gov Identifier: NCT01814969). The study is sti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f8eed7d439367b468ba715e3a7b32aa
https://pubmed.ncbi.nlm.nih.gov/33618522
https://pubmed.ncbi.nlm.nih.gov/33618522
Autor:
Agata Kurczyk, Marta Gawin, Joanna Polanska, Piotr Widlak, Katarzyna Frątczak, Monika Pietrowska, Ewa Stobiecka
Publikováno v:
Endocrine pathology. 30(4)
Intra-tumor heterogeneity results from both genetic heterogeneity of cancer (sub)clones and phenotypic plasticity of cancer cells that could be induced by different local microenvironments. Here, we used mass spectrometry imaging (MSI) to compare mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e75680e4a05e1a1754589c98962580
https://pubmed.ncbi.nlm.nih.gov/31664609
https://pubmed.ncbi.nlm.nih.gov/31664609
Autor:
Katarzyna Behrendt, Katarzyna Galwas-Kliber, Ewa Stobiecka, Ewa Chmielik, Adam Idasiak, Iwona Wzietek, Rafał Suwiński, Mariusz Kryj
The study was prospectively designed as a single-arm, single-institution prospective trial of pre-operative concomitant hyperfractionated radiotherapy (HART) with co-administration of chemotherapy based on 5-fluorouracil (5FU) in patients with T2/N+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8895cdfcad96c7260a674150250f8142
https://europepmc.org/articles/PMC5602173/
https://europepmc.org/articles/PMC5602173/
